| |
| |
|
| Insider
Information: |
Fmr Corp |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
32 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
55,020,234 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$672,780,633 |
|
|
| Total
Shares |
55,020,234 |
|
|
| Total
Value |
$672,780,633 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -153.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ironwood Pharmaceuticals Inc |
IRWD |
Edward C. Johnson 3d, ... |
|
0 |
2012-07-10 |
2,340,891 |
Premium* |
|
|
Exa Corp |
EXA |
See Remark 1 |
2012-07-03 |
0 |
2016-09-30 |
0 |
Premium* |
|
|
Insmed Inc |
INSM |
Edward C. Johnson 3d, ... |
|
0 |
2013-07-22 |
2,221 |
Premium* |
|
|
Tetraphase Pharmaceuticals Inc |
TTPH |
See Remark 1 |
2015-03-05 |
0 |
2013-03-25 |
2,141,645 |
Premium* |
|
|
GT Advanced Technologies Inc |
GTAT |
Edward C. Johnson 3d |
|
0 |
2014-05-27 |
1,078,006 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
See Remark 1. |
2014-01-30 |
0 |
2014-08-01 |
1,457,994 |
Premium* |
|
|
Generac Holdings Inc. |
GNRC |
See Remark 1, 10% Owner |
2014-07-01 |
0 |
2014-07-01 |
763,071 |
Premium* |
|
|
Blueprint Medicines Corp |
BPMC |
See Remark 1 |
2015-05-05 |
0 |
2015-11-27 |
264,898 |
Premium* |
|
|
Coherus Biosciences, Inc. |
CHRS |
See Remark 1 |
|
0 |
2016-08-08 |
361,594 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
See Remark 1 |
|
0 |
2016-05-17 |
489,880 |
Premium* |
|
|
Aclaris Therapeutics, Inc. |
ACRS |
10% Owner |
2015-10-13 |
0 |
2017-08-11 |
326,617 |
Premium* |
|
|
Dimension Therapeutics, Inc. |
DMTX |
See Remark 1 |
|
0 |
2017-11-07 |
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
See Remark 1 |
2016-02-17 |
0 |
2017-03-13 |
243,508 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
See Remark 1 |
|
0 |
2018-08-08 |
606,356 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
See Remark 1 |
|
0 |
2017-07-03 |
1,715,935 |
Premium* |
|
|
Cogent Biosciences, Inc. |
COGT |
See Remark 1 |
2018-04-03 |
0 |
2018-04-03 |
23,240 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
See Remark 1, 10% Owner |
2018-04-23 |
0 |
2018-04-23 |
1,888,986 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
See Remark 1 |
2017-12-12 |
0 |
2017-12-12 |
783,216 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
See Remark 1 |
2018-01-29 |
0 |
2018-01-29 |
1,118,054 |
Premium* |
|
|
Precision Biosciences Inc |
DTIL |
See Remark 1 |
2019-04-01 |
0 |
2019-04-01 |
3,738,248 |
Premium* |
|
|
Orchard Therapeutics Plc |
ORTX |
See Remark 1, 10% Owner |
|
0 |
2021-02-19 |
4,099,540 |
Premium* |
|
|
Beam Therapeutics Inc. |
BEAM |
See Remark 1 |
2020-02-10 |
0 |
2024-02-14 |
1,235,511 |
Premium* |
|
|
Flywire Corp |
FLYW |
See Remark 1 |
|
0 |
2021-05-28 |
14,728,818 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
See Remark 1, 10% Owner |
2021-06-21 |
0 |
2022-07-12 |
570,729 |
Premium* |
|
|
Caribou Biosciences, Inc. |
CRBU |
See Remark 1 |
2021-07-27 |
0 |
2021-07-27 |
1,464,775 |
Premium* |
|
|
Rallybio Corp |
RLYB |
See Remark 1 |
2021-08-02 |
0 |
2021-08-02 |
1,694,388 |
Premium* |
|
|
Xilio Therapeutics, Inc. |
XLO |
See Remark 1 |
|
0 |
2021-10-26 |
30,780 |
Premium* |
|
|
Prime Medicine, Inc. |
PRME |
See Remark 1 |
2022-10-24 |
0 |
2022-10-24 |
4,228,589 |
Premium* |
|
|
Structure Therapeutics Inc. |
GPCR |
10% Owner |
2023-02-07 |
0 |
2023-10-02 |
785,364 |
Premium* |
|
|
Turnstone Biologics Corp. |
TSBX |
See Remark 1, 10% Owner |
2023-07-25 |
0 |
2023-07-25 |
4,939 |
Premium* |
|
|
Neumora Therapeutics, Inc. |
NMRA |
See Remark 1 |
|
0 |
2023-09-19 |
2,000,018 |
Premium* |
|
|
Sana Biotechnology, Inc. |
SANA |
|
|
0 |
2024-04-01 |
4,832,423 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLO |
Xilio Therapeutics, Inc. |
10% Owner |
– – • |
2021-10-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
26,315 |
|
- |
|
| XLO |
Xilio Therapeutics, Inc. |
See Remark 1 |
– – – |
2021-10-26 |
4 |
A |
$0.00 |
$0 |
I/I |
1,881,355 |
4,465 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
See Remark 1 |
– – – |
2018-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,118,054 |
1,118,054 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
10% Owner |
– – • |
2016-03-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,989,923 |
|
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-03-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,105,202) |
6,884,721 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-03-30 |
4 |
S |
$8.46 |
$242,472 |
I/I |
(28,661) |
6,856,060 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-03-31 |
4 |
S |
$8.49 |
$979,878 |
I/I |
(113,877) |
6,742,183 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-03 |
4 |
S |
$7.94 |
$827,405 |
I/I |
(104,006) |
6,638,177 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-04 |
4 |
S |
$7.95 |
$1,055,498 |
I/I |
(132,767) |
6,505,410 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-05 |
4 |
S |
$7.80 |
$496,314 |
I/I |
(63,630) |
6,441,780 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-06 |
4 |
S |
$7.73 |
$23,963 |
I/I |
(3,100) |
6,438,680 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-07 |
4 |
S |
$7.68 |
$386,882 |
I/I |
(48,950) |
6,389,730 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-10 |
4 |
S |
$7.67 |
$1,387,997 |
I/I |
(178,556) |
6,211,174 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-11 |
4 |
S |
$7.34 |
$605,092 |
I/I |
(81,814) |
6,129,360 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-12 |
4 |
S |
$7.41 |
$723,809 |
I/I |
(97,680) |
6,031,680 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-13 |
4 |
S |
$7.27 |
$861,677 |
I/I |
(115,860) |
5,915,820 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-17 |
4 |
S |
$7.24 |
$651,317 |
I/I |
(89,700) |
5,826,120 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-18 |
4 |
S |
$6.98 |
$124,909 |
I/I |
(17,517) |
5,808,603 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-19 |
4 |
S |
$6.90 |
$195,680 |
I/I |
(28,264) |
5,780,339 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-20 |
4 |
S |
$6.88 |
$502,433 |
I/I |
(72,972) |
5,707,367 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-21 |
4 |
S |
$6.83 |
$161,034 |
I/I |
(23,505) |
5,683,862 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2017-04-24 |
4 |
S |
$6.60 |
$517,299 |
I/I |
(77,634) |
5,606,228 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – – |
2017-04-25 |
4 |
S |
$6.69 |
$722,372 |
I/I |
(106,781) |
5,499,447 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2018-07-25 |
4 |
S |
$11.95 |
$921,276 |
I/I |
(77,039) |
1,917,922 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
See Remark 1 |
– – • |
2018-07-26 |
4 |
S |
$12.01 |
$2,651,794 |
I/I |
(218,811) |
1,699,111 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
